Beta Drugs Limited
Ashish Kacholia reduced his stake in Beta Drugs Limited from 12.47 percent to 11.04 percent, selling 40,000 shares across his holdings.
A pharmaceutical manufacturer specializing in oncology drugs, Beta Drugs Ltd produces a comprehensive range of anti-cancer medications serving patients across India and international markets. The company operates through both domestic and export channels, distributing its products to institutional buyers, hospitals, and retail segments within the healthcare sector. Its focused expertise in oncology therapeutics and manufacturing capabilities position it within the critical healthcare segment addressing cancer treatment needs across emerging and established markets worldwide.
The 'Big Whale' of Dalal Street has an uncanny talent for spotting tomorrow's multibaggers today. Mumbai-based founder of Lucky Securities (ex-Hungama Digital co-founder with Rakesh Jhunjhunwala), Ashish Kacholia built his career at Prime Securities and Edelweiss before going full-time on his own book. His early calls on Skipper, Xpro India, and MTAR Technologies delivered 5-20x returns to investors who tracked his filings. He runs a ~₹2,370 Cr publicly disclosed portfolio across 49 stocks, almost entirely small- and mid-cap compounders picked for management quality and scalable business models. Find a quality small-cap before the crowd? Kacholia already owns it.